1.75
Overview
News
Price History
Option Chain
Financials
Why PETS Down?
Discussions
Forecast
Stock Split
Dividend History
Petmed Express Inc stock is traded at $1.75, with a volume of 104.99K.
It is down -2.78% in the last 24 hours and down -22.22% over the past month.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
See More
Previous Close:
$1.80
Open:
$1.8
24h Volume:
104.99K
Relative Volume:
0.91
Market Cap:
$37.39M
Revenue:
$182.67M
Net Income/Loss:
$-64.87M
P/E Ratio:
-0.561
EPS:
-3.1193
Net Cash Flow:
$-22.92M
1W Performance:
-4.89%
1M Performance:
-22.22%
6M Performance:
-52.05%
1Y Performance:
-48.83%
Petmed Express Inc Stock (PETS) Company Profile
Name
Petmed Express Inc
Sector
Industry
Phone
(561) 426-4444
Address
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, SCNX, POM, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PETS
Petmed Express Inc
|
1.75 | 37.39M | 182.67M | -64.87M | -22.92M | -3.1193 |
|
HITI
High Tide Inc
|
2.31 | 202.98M | 452.61M | -35.30M | 13.25M | -0.3863 |
|
SCNX
Scienture Holdings Inc
|
0.3818 | 15.51M | 656.60K | -16.79M | -11.12M | -1.0743 |
|
POM
Pomdoctor Ltd Adr
|
0.0719 | 9.65M | 0 | 0 | 0 | 0.00 |
|
WGRX
Wellgistics Health Inc
|
3.39 | 8.52M | 14.03M | -76.59M | -13.73M | -41.45 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-25-23 | Initiated | Lake Street | Buy |
| Jan-20-22 | Upgrade | Sidoti | Neutral → Buy |
| Nov-18-21 | Initiated | Morgan Stanley | Underweight |
| Oct-01-21 | Initiated | Jefferies | Hold |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jun-03-21 | Downgrade | Sidoti | Buy → Neutral |
| Mar-05-21 | Upgrade | Sidoti | Neutral → Buy |
| Jan-27-21 | Downgrade | Sidoti | Buy → Neutral |
| Aug-19-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-09-20 | Downgrade | Sidoti | Buy → Neutral |
| Mar-12-20 | Upgrade | Sidoti | Neutral → Buy |
| Feb-24-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-16-19 | Downgrade | Craig Hallum | Buy → Hold |
| Jun-15-18 | Initiated | CL King | Neutral |
| Aug-24-17 | Upgrade | Sidoti | Neutral → Buy |
| Jul-24-17 | Upgrade | Northcoast | Neutral → Buy |
| May-09-16 | Upgrade | Craig Hallum | Sell → Hold |
| Feb-04-16 | Initiated | Credit Suisse | Underperform |
| Jul-19-10 | Downgrade | CL King | Strong Buy → Accumulate |
| Jul-19-10 | Reiterated | JMP Securities | Mkt Outperform |
| May-25-10 | Downgrade | Wedbush | Neutral → Underperform |
| May-06-10 | Reiterated | Wedbush | Neutral |
| Mar-23-10 | Downgrade | Janney Mntgmy Scott | Buy → Neutral |
| Mar-18-10 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-16-10 | Reiterated | CL King | Strong Buy |
| Jul-21-09 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-09 | Initiated | CL King | Strong Buy |
View All
Petmed Express Inc Stock (PETS) Latest News
Petmed Express Inc (PETS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Petmed Express Inc (PETS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Petmed Express Inc (PETS) Institutional Confidence - TradingKey
Petmed Express Inc (PETS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Petmed Express Inc (PETS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PetMed Express StockAnalyst views and operations midweek - AD HOC NEWS
Petmed Express Inc (PETS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PETS News | PETMED EXPRESS INC (NASDAQ:PETS) - ChartMill
Q4 2026 Petmed Express Inc Earnings Call Transcript - GuruFocus
Petmed Express Inc (PETS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Petmed Express Inc (PETS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Petmed Express Inc (PETS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PETMED EXPRESS INC (PETS) Stock Chart - ChartMill
NINA CAPITAL HOLDINGS INC. Increases Stake in PetMed Express Inc (PETS) - GuruFocus
Nina Capital Holdings buys $43,725 of PetMed Express common stock By Investing.com - Investing.com Nigeria
Nina Capital Holdings buys $43,725 of PetMed Express common stock - Investing.com
Nina Capital buys 25,000 PetMed Express (PETS) shares in market - Stock Titan
PETS Q4 earnings call focuses on turnaround foundation - MSN
PETS Q4 Earnings Call Focuses on Turnaround Foundation - TradingView
PetMed Express (PETS) Q4 2026 Earnings Transcript - AOL.com
PetMed outlines $6.1M annualized savings while staying independent after $4-$4.25 proposals - MSN
PetMeds 2026 Annual Report: Strategic Growth, Customer Care, and Competitive Position in Pet Pharmacy E-Commerce - Minichart
PETS: Company Evaluates Acquisition Proposals but Remains Indepe - GuruFocus
PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navi - GuruFocus
PetMed Express Inc (PETS) Stock Price, Trades & News - GuruFocus
Is PetMed Express Inc (PETS) Overselling Its Growth Potential? Q - GuruFocus
PetMed Express Q4 2026 Earnings Call Transcript - MarketBeat
PETS Reports Q4 Revenue Decline While Aiming for Future Growth - GuruFocus
PetMed Express (PETS) Reports Q4 Fiscal 2026 Earnings Amid Restr - GuruFocus
PetMed Express earnings missed by $0.06, revenue fell short of estimates - Investing.com Canada
PetMed FQ4 profit misses outlook, dismisses acquisition offers (PETS:NASDAQ) - Seeking Alpha
PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
PETMED EXPRESS INC FY 2026: Revenue $179.02M, EPS ($2.74) — 10-K Summary - TradingView
PetMed Express (NASDAQ: PETS) highlights going-concern review and control weaknesses - Stock Titan
PetMed Express Reports Q4 2026 Results: Full Earnings Call Transcript - Benzinga
PetMed Express Fiscal Q4 Loss Narrows, Revenue Falls - Moomoo
PetMed: Fiscal Q4 Earnings Snapshot - marketscreener.com
PetMed Express reports FY2026 sales $179.0M, net loss $57.3M; Q4 sales $42.8M - TradingView
PetMed Express misses Q4 earnings, revenue estimates; Shares edge lower - Investing.com
PetMed Express misses Q4 earnings, revenue estimates; Shares edge lower By Investing.com - Investing.com India
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results - The Manila Times
PetMed Express Q4 revenue falls on prescription sales decline - TradingView
PetMed Express (PETS) revenue falls 21% as goodwill charge drives $57M loss - Stock Titan
PETS: FY26 net loss widened on lower sales and one-time charges; B2B and cost initiatives underway - TradingView
BRIEF-Petmed Express Q4 Revenue USD 42.8 Million - TradingView
PetMeds rejects $4.00–$4.25 a share bids, remains independent - Stock Titan
PetMed Express Inc stock (US7167831061): Investors watch ahead of next earnings date estimate - AD HOC NEWS
Petmed Express Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
PetMed Express, Inc.Common Stock (NQ: PETS - FinancialContent
PetMeds on the Brink: Investors Await Critical Year-End Financials - BriefGlance
PetMed Express to Release Fourth Quarter and Fiscal Year 2026 Financial Results on June 2, 2026 - geneonline.com
Petmed Express Inc Stock (PETS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):